Founded in 1986, Shire Pharmaceuticals Group plc is a rapidly growing international emerging pharmaceutical company with revenues for the full year 2002 of $1,037.3 million and an operating income of $327.038 million. The growth rates for revenues were 22% for 2002.
Shire intends to grow both organically and by acquisition. The business development team at Shire focuses on the ‘search’ aspect of the Search and Development strategy.
They are mainly involved in the acquisition of companies and in- and out-licensing
of marketed products and development projects. For more information, click
on the appropriate link above.
We aim to provide high quality and effective products that enhance the health and quality of life of people around the world and contribute to the long-term business success of our company, to the benefit of all our stakeholders.
We are driven
by the needs of all our stakeholders: patients, their families and caregivers,
doctors and medical specialists, employees and partner companies, the
community in which we live and work and of course our shareholders.
treatment osteoperosis
We also want to be the employer of choice in our sector, attracting and retaining highly skilled and talented people who play an active part in the development of our company by rewarding excellence and recognising individual contributions - treatment osteoperosis
We are guided
by our values: dynamism, integrity, caring and innovation, which govern
our day-to-day actions that will all, ultimately, ensure that we achieve
our mission.
alzheimers products
exputex
shire laboratories
specialty and pharmaceutical companies
bipolar disorder and epilepsy
amatine and shire
pharmaceuticals company in singapore
As part of our history
we have acquired and merged with a number of other companies. This has
led to a wide ranging portfolio of products not always within our primary
therapeutic areas of interest. However, these products are useful for
many patients and together continue to provide strong revenues that we
are able to plough back into the development of new products for the future
benefit of many more patients.
Shire Laboratories Inc.(SLI)
Shire Laboratories Inc.(SLI) is an advanced drug delivery company, which offers a full range of technologies and development capabilities. Shire dedicates multidisciplinary teams of highly experienced scientists to solve its partners' drug delivery problems covering all phases of projects from cell-based screening and pre-formulation to scale-up and commercialisation.
Our mission is to become the leading company in meeting the needs of the specialist physician.
We want to achieve this by developing and marketing products of the highest quality for the treatment of serious diseases, which are treated by medical specialists.